Study to Evaluate Single Inhaled Doses of PT001, PT003, PT005 and PT001 Plus PT005 in Healthy Subjects

NCT00893971 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: PT001
DRUG: PT005
DRUG: PT003
DRUG: PT001 + PT005

Sponsor

Pearl Therapeutics, Inc.